The Molecular Biology Core has been in operation for the past fourteen years and has provided state-of-the-art methodologies for numerous molecular biological techniques and recombinant protein expression and purification. Operating funds for the Molecular Biology Core have come from the UAB CFAR and through a chargeback mechanism for services rendered. As the visibility and reputation of the Core has increased, the use by Comprehensive Cancer Center (CCC) members on non-CFAR projects have increased to approximately 50% of the Core activities. This is due in part to the success of CCC members for Breast and Brain Tumor SPORES and several joint program projects. To keep servicing the CCC members at an affordable cost, we are proposing to establish a joint CFAR/CCC Core with the following goals:
Specific Aim 1 : To train personnel (technology transfer) to assist in the various phases of plasmid construction, PCR, mutagenesis and expression/purification of recombinant proteins.
Specific Aim 2 : To provide the following contract services to CCC members at reduced costs: Plasmid DNA preparation, subcloning, recombinant protein expression, PCR and DNA mutagenesis. During the last fourteen years of operation, the Molecular Biology Core has assisted on average over twenty CCC members per year. The Core has averaged $40,000/year in chargebacks from CCC members. Most recently, the Core has provided expertise and service to CCC members engaged in Breast and Brain Tumor SPORE and joint programs projects between UAB and SRI designed to develop new suicide gene methods for cancer. We are requesting support for Core personnel to maintain the multi-disciplinary efforts to the Core and to keep costs affordable to all CCC members. The majority of the requested money then will be salary for key shared resource personnel (David McPherson) that is distinct from the supported CFAR Core personnel (Sylvia McPherson).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-38
Application #
7789514
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-04-01
Budget End
2010-03-31
Support Year
38
Fiscal Year
2009
Total Cost
$172,665
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988
Toboni, Michael D; Smith, Haller J; Bae, Sejong et al. (2018) Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database. Int J Gynecol Cancer 28:1427-1431
Dionne-Odom, J Nicholas; Applebaum, Allison J; Ornstein, Katherine A et al. (2018) Participation and interest in support services among family caregivers of older adults with cancer. Psychooncology 27:969-976
Demark-Wahnefried, Wendy; Schmitz, Kathryn H; Alfano, Catherine M et al. (2018) Weight management and physical activity throughout the cancer care continuum. CA Cancer J Clin 68:64-89
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Gowda, Pramod S; Wildman, Benjamin J; Trotter, Timothy N et al. (2018) Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression. Mol Cancer Res 16:1138-1148
Dix, Daniel B; McDonald, Andrew M; Gordetsky, Jennifer B et al. (2018) How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer? Urology 122:139-146
Prince, Andrew C; Moore, Lindsay S; Tipirneni, Kiranya E et al. (2018) Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer. Surg Oncol 27:225-230
Gangrade, Abhishek; Pathak, Vibha; Augelli-Szafran, Corinne E et al. (2018) Preferential Inhibition of Wnt/?-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer. Int J Mol Sci 19:

Showing the most recent 10 out of 747 publications